Loss of CD20 expression in relapsed diffuse large b-cell lymphoma: Clinical significance of an uncommon pathological finding

被引：0
|
作者：
Mitra, Subhashis [1 ]
Mukherjee, Sanghamitra [1 ]
Bhattacharyya, Maitreyee [2 ]
Chakraborty, Hema [1 ]
机构：
[1] AMRI Hosp, Dept Pathol, Kolkata 700029, W Bengal, India
[2] Med Coll & Hosp, Inst Hematol & Transfus Med, Kolkata, W Bengal, India
来源：
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY | 2016年 / 59卷 / 02期
关键词：
COMBINATION;
D O I：
10.4103/0377-4929.182026
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [31] Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab
    Sonoki, Takashi
    Li, Yaqiong
    Miyanishi, Setsuko
    Nakamine, Hirokazu
    Hanaoka, Nobuyoshi
    Matsuoka, Hiroshi
    Mori, Ichiro
    Nakakuma, Hideki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 400 - 402
  • [32] Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo
    Damm J.K.
    Gordon S.
    Ehinger M.
    Jerkeman M.
    Gullberg U.
    Hultquist A.
    Drott K.
    Experimental Hematology & Oncology, 4 (1)
  • [33] A real-world experience: Outcomes among relapsed/refractory diffuse large B cell lymphoma patients with CD20 loss.
    Takiar, Radhika
    Boonstra, Philip S.
    Karimi, Yasmin
    Carty, Shannon
    Wilcox, Ryan A.
    Phillips, Tycel Jovelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Expression of Histone Deacetylases in Diffuse Large B-cell Lymphoma and Its Clinical Significance
    Lee, Sung Hak
    Yoo, Changyoung
    Im, Soyoung
    Jung, Ji-Han
    Choi, Hyun Joo
    Yoo, Jinyoung
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (10): : 994 - 1000
  • [35] The significance of single nucleotide polymorphism rs2070770 in CD20 gene in Chinese patients with diffuse large B-cell lymphoma
    Zhang, Li-Na
    Wang, Li
    Fang, Cheng
    Zou, Zhi-Jian
    Fan, Lei
    Zhang, Run
    Young, Ken H.
    Li, Jian-Yong
    Xu, Wei
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 676 - 681
  • [36] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Duman, Berna Bozkurt
    Sahin, Berksoy
    Ergin, Melek
    Guvenc, Birol
    MEDICAL ONCOLOGY, 2012, 29 (02) : 1223 - 1226
  • [37] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Berna Bozkurt Duman
    Berksoy Şahin
    Melek Ergin
    Birol Guvenc
    Medical Oncology, 2012, 29 : 1223 - 1226
  • [38] Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma
    Horvat, Mateja
    Prevodnik, Veronika Kloboves
    Lavrencak, Jaka
    Novakovic, Barbara Jezersek
    ONCOLOGY REPORTS, 2010, 24 (04) : 1101 - 1107
  • [39] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [40] Management of Relapsed Diffuse Large B-cell Lymphoma
    Crump, Michael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1195 - +
12345